Get the Stockscreener App
4.15
0.95%
-0.04
After Hours:
4.15
Aquestive Therapeutics Inc stock is traded at $4.15, with a volume of 835.94K.
It is down -0.95% in the last 24 hours and up +3.23% over the past month.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
See More
Previous Close:
$4.19
Open:
$4.19
24h Volume:
835.94K
Relative Volume:
0.19
Market Cap:
$506.49M
Revenue:
$44.55M
Net Income/Loss:
$-83.78M
P/E Ratio:
-5.3383
EPS:
-0.7774
Net Cash Flow:
$-52.99M
1W Performance:
+0.48%
1M Performance:
+3.23%
6M Performance:
-39.68%
1Y Performance:
+64.68%
1-Day Range:
$4.12
$4.26
1-Week Range:
$4.04
$4.28
52-Week Range:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Name
Aquestive Therapeutics Inc
Sector
Phone
908-941-1900
Address
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.15 | 497.94M | 44.55M | -83.78M | -52.99M | -0.7774 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.74 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Piper Sandler | Overweight |
| Mar-28-24 | Initiated | Raymond James | Outperform |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Apr-22-19 | Initiated | H.C. Wainwright | Buy |
| Jan-03-19 | Initiated | Lake Street | Buy |
| Aug-20-18 | Initiated | JMP Securities | Mkt Outperform |
| Aug-20-18 | Initiated | RBC Capital Mkts | Outperform |
View All
Aquestive Therapeutics Inc Stock (AQST) Latest News
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Bragar Eagel & Squire Reminds Aquestive Investors of Upcoming Lead Plaintiff Deadline - National Today
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors They Have Until ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors They Have Until May 4th to Seek Lead Plaintiff Role - GlobeNewswire Inc.
Aquestive Therapeutics (AQST) CEO awarded 293,100 performance stock units tied to share price - Stock Titan
Aquestive Therapeutics (AQST) grants 60,000 performance stock units to officer - Stock Titan
Aquestive (AQST) COO awarded 60,000 PSUs tied to 2025–2028 share performance - Stock Titan
Aquestive Therapeutics (AQST) CFO receives 82,500 performance stock units tied to share price - Stock Titan
Aquestive (AQST) CCO receives 67,500 performance stock units tied to share price - Stock Titan
Aquestive Therapeutics (AQST) awards 82,500 performance stock units to corporate secretary - Stock Titan
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to ... - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - GlobeNewswire
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - mydailyrecord.com
2026-04-12 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Press releases provided by CNW - Techaeris
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Aquestive Therapeutics, Inc. ... - Bluefield Daily Telegraph
Aquestive Therapeutics (AQST) Form 3 shows CLO holding zero common stock - Stock Titan
AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire
Aquestive Therapeutics, Inc. (AQST) stock price, news, quote and history - Yahoo Finance UK
Investment Report: What is the earnings history of Aquestive Therapeutics IncIPO Watch & Weekly Momentum Picks - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - PR Newswire
AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT - GlobeNewswire
ROSEN Law Firm Encourages Aquestive Therapeutics Investors to Seek Legal Counsel - National Today
ROSEN, A LOGNSTANDING FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionAQST - ACCESS Newswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST - ChartMill
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - TMX Newsfile
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Aquestive Therapeutics, Inc. Securities Class Action Lawsuit -- The Gross Law Firm - PR Newswire
2026-04-07 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Holzer & Holzer, LLC Reminds Investors of Lead Plaintiff - GlobeNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With ... - Caledonian Record
AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Aquestive Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
2026-04-05 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Aquestive Therapeutics, Inc. to Contact the Firm Today! | NDAQ:AQST | Press Release - Stockhouse
Published on: 2026-04-05 15:45:00 - baoquankhu1.vn
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Aquestive Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
AQST Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
AQST SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Aquestive T - GuruFocus
AQST SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire
Lake Street adjusts Aquestive Therapeutics, Inc. (AQST) valuation model on expected approval delay - MSN
Bernstein Liebhard LLP Reminds Aquestive Shareholders of Lawsuit - National Today
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - bdtonline.com
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) ... - bdtonline.com
Aquestive Therapeutics Inc Stock (AQST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.06%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):